Results 241 to 250 of about 5,459 (278)
Some of the next articles are maybe not open access.

Counterfeiting of medicinal drugs: issues and threats

Fundamental & Clinical Pharmacology, 2005
AbstractThe increasing counterfeiting of medicinal drugs is a very worrying phenomenon, especially in developing countries. The risk for public health is quite real, particularly as these products are often sold out of any controlled distribution channel.
Yves, Juillet, Anne-Priscille, Vlasto
openaire   +2 more sources

Counterfeit drug risk

Practice Nursing, 2006
From April, nurses who have undertaken the extended prescribing course will be able to prescribe from the full British National Formulary (BNF) for any condition within their competence. Clinical practice will not change immediately because the majority of nurses are not yet trained prescribers.
openaire   +1 more source

Counterfeit Drugs: A Review

Asian Journal of Pharmacy and Technology, 2016
Counterfeit drugs are market from a big portion of India's domestic drug market. Indian government point out that 0.4 percent of countries drugs is counterfeit. World Health Organisation estimated that the counterfeit drugs make up about 25 percent in developed countries.
openaire   +1 more source

Counterfeiting in performance‐ and image‐enhancing drugs

Drug Testing and Analysis, 2009
AbstractThe current drastic escalation in obesity may be contributing to the exponential rise in drugs used for image enhancement. Drugs such as anabolic‐androgenic steroids (AAS) are perceived as a viable method of achieving a perfect physique. They are also the most widely abused drugs in sport.
Graham, Michael R.   +10 more
openaire   +3 more sources

Fade to Black: Importation and Counterfeit Drugs

American Journal of Law & Medicine, 2006
Americans rely extensively upon prescription medications to maintain health and quality of life. According to the National Center for Health Statistics, in 2002, at least 1.5 billion drugs were prescribed to patients in physician offices, 196 million in US emergency departments, and 140 million in outpatient settings.
openaire   +2 more sources

Roles for pharmacy in combatting counterfeit drugs

Journal of the American Pharmacists Association, 2008
To describe (1) the international scope of counterfeit drugs, (2) international and U.S. anticounterfeiting initiatives, and (3) the enhanced roles and challenges facing pharmaceutical organizations and individual pharmacists to thwart counterfeit drugs.PubMed and Ovid from 1970 to 2008 using the search terms counterfeit drugs, counterfeit ...
openaire   +2 more sources

Forensic pharmacovigilance and substandard or counterfeit drugs

International Journal of Risk & Safety in Medicine, 2012
Identification of harm in the form of adverse drug reactions that are caused by counterfeit or other substandard medicinal products by application of standard pharmacovigillance methods of registration, analysis and investigation could be forensic pharmacovigillance.
openaire   +2 more sources

Counterfeit antimalarial drugs

The Lancet Infectious Diseases, 2012
David, Reddy, Jaya, Banerji
openaire   +2 more sources

Counterfeit and substandard drugs

Clinical Pharmacology & Therapeutics, 2001
M M, Reidenberg, B A, Conner
openaire   +2 more sources

Health and Economic Consequences of Counterfeit Drugs

Clinical Pharmacology & Therapeutics, 2009
"Counterfeit Drugs Kill" is the slogan the World Health Organization (WHO) uses in its anti-counterfeiting campaign. International organizations, governments of developed and developing countries, and the pharmaceutical industry created the IMPACT initiative (International Medical Products Anti-Counterfeiting Taskforce) to take on the thriving illegal ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy